A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection-Reference-Cited by-同舟云学术

A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection

Published:2009-02 Issue:2 Volume:50 Page:370-376
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Berres Marie-Luise,Papen Sven,Pauels Katrin,Schmitz Petra,Zaldivar Mirko Moreno,Hellerbrand Claus,Mueller Tobias,Berg Thomas,Weiskirchen Ralf,Trautwein Christian,Wasmuth Hermann E.

Publisher

Elsevier BV

Subject

Hepatology

Reference37 articles.

1. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups;Poynard;Lancet,1997

2. Peginterferon and ribavirin for chronic hepatitis C;Hoofnagle;N Engl J Med,2006

3. Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors;Missiha;Gastroenterology,2008

4. Liver fibrosis;Bataller;J Clin Invest,2005

5. Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference;Friedman;Hepatology,2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis;BMC Cancer;2024-08-23

2. Prognostic and predictive role of YKL-40 in anal squamous cell carcinoma: a serological and tissue-based analysis in a multicentric cohort;Frontiers in Medicine;2024-07-09

3. Association between chitinase-3-like protein 1 and metabolic-associated fatty liver disease in patients with type 2 diabetes mellitus;Irish Journal of Medical Science (1971 -);2024-03-23

4. Diagnostic Value of Serum Chitinase-3-Like Protein 1 for Liver Fibrosis: A Meta-analysis;BioMed Research International;2022-03-20

5. Increased Levels of CHI3L1 and HA Are Associated With Higher Occurrence of Liver Damage in Patients With Obstructive Sleep Apnea;Frontiers in Medicine;2022-02-25